Eris Lifesciences Acquires Velbiom Probiotics' Branded Probiotic Products for INR 50 cr.

Eris Lifesciences Ltd. has approved the execution of a Business Transfer Agreement (BTA) with Velbiom Probiotics Private Limited for the acquisition of their Branded Probiotic Products on a slump sale basis. The acquisition includes various formulations of prebiotics and probiotics for metabolic health, gut wellness, and women’s health. The revenue of the acquired business over the last three years was INR 16.02 cr. (9M FY26), INR 19.64 cr. (FY25), and INR 17.56 cr. (FY24). The agreement is for the acquisition of the Business as a going concern on a slump sale basis by the Company for a Consideration of INR 50 cr. (Indian Rupees Fifty Crore only).